Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term Follow-up Study of Patients Who Received MB-105

NCT07340814 is registered in ClinicalTrials.gov with March Biosciences Inc as lead sponsor.

NCT NCT07340814
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07340814 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term Follow-up Study of Patients Who Received MB-105
Lead sponsor
March Biosciences Inc
Phase
Observational
Overall status
Not yet recruiting
Start date
February 27, 2026
Completion date
October 15, 2040
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

any patient treated with mb-105